Trump White House to Announce Tylenol Use in Pregnancy Linked to Autism: Report

President Donald Trump’s White House is reportedly set to announce Monday that using Tylenol, or generic acetaminophen, during pregnancy may contribute to increased cases of autism.

Two senior administration officials who spoke on the condition of anonymity shared the brief with Politico and added that the White House would highlight leucovorin, used in cancer and anemia treatments, as a potential therapy for people with autism.

Trump teased Friday that his administration “maybe” has “a reason why” autism is “totally out of control” after having tasked Health Secretary Robert F. Kennedy Jr. to spearhead research into its causes.

Kennedy, who has questioned mainstream science debunking links to vaccines, promised in August to work alongside NIH director Jay Bhattacharya and FDA commissioner Marty Makary to deliver answers by September.

The White House said Sunday that Monday’s announcement “will make historic progress” in addressing autism, which affects 1 in 31 American 8-year-olds, according to the CDC.

Medical officials, however, are divided on the Tylenol claim, Politico reported, with Kennedy himself reportedly reluctant to issue a warning.

Tylenol’s parent company, Kenvue, has already hit back, insisting: “There is no credible evidence linking acetaminophen to autism.”

Earlier this month, Kenvue CEO Kirk Perry urged Kennedy not to list Tylenol as a cause of autism, arguing there is no correlation between the two, the Wall Street Journal reported.

Major medical organizations continue to advise that acetaminophen is safe when used prudently during pregnancy.